Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Statement re Offer for Subscription

16 Jun 2021 15:16

RNS Number : 1437C
Maven Income and Growth VCT 3 PLC
16 June 2021
 

Maven Income and Growth VCT 3 PLC and Maven Income and Growth VCT 4 PLC

(the "Companies")

 

Statement re Intended Joint Offers for Subscription

 

The directors of the Companies are pleased to announce the intention to raise up to £20 million, in aggregate, by way of joint offers for subscription of new ordinary shares, with over-allotment facilities of up to, in aggregate, a further £20 million (the "Offers"), with shares to be issued in the 2021/22 and 2022/23 tax years.

The Boards are confident that, given the strength of the current pipeline of investment opportunities, the Companies' investment manager, Maven Capital Partners UK LLP, will continue to be able to identify and complete VCT qualifying transactions in line with each Company's investment strategy.

A prospectus, with full details of the Offers, is intended for publication in early September 2021. A further announcement will be made when the prospectus is available.

Applicants will be able to invest in either one or both of the Offers, in accordance with the terms to be set out in the prospectus and subject to the relevant Offer selected remaining open.

It is anticipated that the Offers will remain open until no later than 4 April 2022 in respect of the 2021/22 tax year and until 27 May 2022 in respect of the 2022/23 tax year, unless an Offer is fully subscribed at an earlier date and subject to each Board's right to close or extend the relevant Offer at any time.

 

On behalf of the Boards

Maven Capital Partners UK LLP

Secretary

16 June 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRZQLFFFQLFBBZ
Date   Source Headline
20th May 202210:03 amRNSIssue of Equity
13th May 20223:24 pmRNSStatement re Dividend Investment Scheme
12th May 20223:19 pmRNSNet Asset Value(s)
11th May 20222:01 pmRNSResult of AGM & Directorate Change
26th Apr 202212:34 pmRNSIssue of Supplementary Prospectus
5th Apr 20226:30 pmRNSIssue of Equity
23rd Mar 20225:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20225:05 pmRNSIssue of Equity
22nd Mar 20223:23 pmRNSAnnual Financial Report
16th Mar 20223:32 pmRNSTransaction in Own Shares
15th Mar 20223:09 pmRNSTransaction in Own Shares
11th Mar 202211:41 amRNSIssue of Equity - Dividend Investment Scheme
10th Mar 202211:30 amRNSIssue of Equity
10th Mar 202211:20 amRNSStatement re Dividend Investment Scheme
10th Mar 202211:04 amRNSNet Asset Value and Proposed Final Dividend
18th Feb 20225:32 pmRNSIssue of Equity - Replacement Announcement
7th Feb 202212:49 pmRNSDirector/PDMR Shareholding
7th Feb 202212:48 pmRNSDirector/PDMR Shareholding
7th Feb 202210:51 amRNSIssue of Equity
4th Feb 20229:46 amRNSNet Asset Value(s)
31st Jan 20224:25 pmRNSStatement re Offer for Suscription
10th Jan 202212:43 pmRNSStatement re Offer for Subscription
5th Jan 202210:35 amRNSDividend Declaration
2nd Dec 20213:37 pmRNSTransaction in Own Shares
11th Nov 20213:25 pmRNSNet Asset Value(s)
20th Oct 20214:44 pmRNSResult of General Meeting
1st Oct 20219:22 amRNSIssue of Equity
28th Sep 20213:22 pmRNSStatement re Dividend Investment Scheme
20th Sep 20215:42 pmRNSStatement re Change of Registrar
20th Sep 20215:21 pmRNSPublication of a Prospectus
7th Sep 20214:47 pmRNSTransaction in Own Shares
31st Aug 20213:27 pmRNSTransaction in Own Shares
27th Aug 20213:23 pmRNSHalf-year Report
24th Aug 20213:42 pmRNSTransaction in Own Shares
23rd Aug 20213:14 pmRNSTransaction in Own Shares
19th Aug 20213:04 pmRNSStatement re NAV and Interim Dividend
16th Jun 20213:16 pmRNSStatement re Offer for Subscription
24th May 20214:45 pmRNSTransaction in Own Shares
21st May 202111:02 amRNSIssue of Equity
17th May 20214:32 pmRNSStatement re Dividend Investment Scheme
12th May 20214:08 pmRNSNet Asset Value(s)
12th May 202112:37 pmRNSResult of AGM
9th Apr 20215:48 pmRNSAnnual Financial Report
24th Feb 20214:20 pmRNSTransaction in Own Shares
23rd Feb 20214:18 pmRNSTransaction in Own Shares
17th Feb 20214:37 pmRNSStatement re NAV and Final Dividend
8th Dec 20203:27 pmRNSTransaction in Own Shares
17th Nov 20204:26 pmRNSTransaction in Own Shares
16th Nov 20204:52 pmRNSTransaction in Own Shares
11th Nov 20205:01 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.